Viewing Study NCT01138202


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2026-03-07 @ 7:19 PM
Study NCT ID: NCT01138202
Status: COMPLETED
Last Update Posted: 2020-07-17
First Post: 2010-06-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
Sponsor: The HIV Netherlands Australia Thailand Research Collaboration
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-11
Start Date Type: None
Primary Completion Date: 2015-12
Primary Completion Date Type: ACTUAL
Completion Date: 2015-12
Completion Date Type: ACTUAL
First Submit Date: 2010-06-04
First Submit QC Date: None
Study First Post Date: 2010-06-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-07-15
Last Update Post Date: 2020-07-17
Last Update Post Date Type: ACTUAL